Skye Bioscience (OTC: SKYE) is a biopharmaceutical company engineering proprietary cannabinoid derivatives to treat glaucoma and other diseases with significant unmet medical needs.
Charlie Health
15 followers
Lenz Therapeutics
3 followers
Bristol-Myers Squibb
322 followers
Walgreens Boots Alliance
145 followers
Viatris
56 followers
NYU Langone Health
52 followers
Alnylam Pharmaceuticals
51 followers
Syneos Health
38 followers
Catalent
36 followers
Parexel
21 followers
PCI Pharma Services
14 followers
Madrigal Pharmaceuticals
10 followers